ProfileGDS5678 / 1428906_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 96% 96% 96% 95% 96% 97% 97% 97% 97% 96% 96% 96% 96% 97% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 18.9074696
GSM967853U87-EV human glioblastoma xenograft - Control 29.0328196
GSM967854U87-EV human glioblastoma xenograft - Control 38.8456396
GSM967855U87-EV human glioblastoma xenograft - Control 48.7293395
GSM967856U87-EV human glioblastoma xenograft - Control 59.0738696
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.0003297
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 28.898197
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.1124397
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.1264597
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 18.912296
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 28.9412696
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.0910996
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 48.9710496
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.1862297